Follow
Samrina Rehman
Samrina Rehman
Medicines Discovery Catapult
Verified email at md.catapult.org.uk - Homepage
Title
Cited by
Cited by
Year
Proteome characterization of cassava (Manihot esculenta Crantz) somatic embryos, plantlets and tuberous roots
K Li, W Zhu, K Zeng, Z Zhang, J Ye, W Ou, S Rehman, B Heuer, S Chen
Proteome Science 8 (1), 1-12, 2010
952010
Molecular phenotypic descriptors of Dupuytren’s disease defined using informatics analysis of the transcriptome
S Rehman, F Salway, JK Stanley, WER Ollier, P Day, A Bayat
The Journal of hand surgery 33 (3), 359-372, 2008
652008
Dupuytren's: a systems biology disease
S Rehman, R Goodacre, PJ Day, A Bayat, HV Westerhoff
Arthritis research & therapy 13 (5), 1-12, 2011
482011
Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes.
W Wruck, K Kashofer, S Rehman, A Daskalaki, D Berg, E Gralka, ...
Scientific data 2, 150068-150068, 2015
452015
Cytokeratin 15 marks basal epithelia in developing ureters and is upregulated in a subset of urothelial cell carcinomas
G Tai, P Ranjzad, F Marriage, S Rehman, H Denley, J Dixon, K Mitchell, ...
PLoS One 8 (11), e81167, 2013
442013
Frontiers: A systems biology approach to deciphering the etiology of steatosis employing patient-derived dermal fibroblasts and iPS cells
J Jozefczuk, K Kashofer, R Ummanni, F Henjes, S Rehman, S Geenen, ...
Frontiers in Systems Physiology 3, 2012
30*2012
Dupuytren’s Disease metabolite analyses reveals alterations following initial short-term fibroblast culturing
S Rehman, Y Xu, W Dunn, PJR Day, HV Westerhoff, R Goodacre, A Bayat
Molecular BioSystems, 2012
222012
Mathematical modelling of miRNA mediated BCR.ABL protein regulation in chronic myeloid leukaemia vis-a-vis therapeutic strategies
M Verma, EG Karimiani, RJ Byers, S Rehman, HV Westerhoff, PJR Day
Integrative Biology 5 (3), 543-554, 2013
192013
Vertical systems biology: from DNA to flux and back.
A Bevilacqua, SJ Wilkinson, R Dimelow, E Murabito, S Rehman, ...
SEB experimental biology series 61, 65, 2008
152008
Systems Biology of Metabolic and Signaling Networks
MA Aon, V Saks, U Schlattner
Berlin, Heidelberg: Springer, 2014
142014
Maps for when the living gets tough: maneuvering through a hostile energy landscape
TDGA Mondeel, S Rehman, Y Zhang, M Verma, P Dürre, M Barberis, ...
IFAC-PapersOnLine 49 (26), 364-370, 2016
52016
SupraBiology 2014: Promoting UK-China collaboration on Systems Biology and High Performance Computing.
E Murabito, R Colombo, C Wu, M Verma, S Rehman, JL Snoep, S Peng, ...
Quant. Biol. 3 (1), 46-53, 2015
32015
Understanding Dupuytren’s disease using systems biology: a move away from reductionism
S Rehman, PJR Day, A Bayat, HV Westerhoff
Front Physiol 3, 316, 2012
22012
Investigating the potential of GalR2 as a drug target for neuropathic pain
K Rich, S Rehman, J Jerman, G Wilkinson
Neuropeptides, 102311, 2022
12022
The control analysis of signal transduction
HV Westerhoff, S Rehman, FC Boogerd, N Yilmaz, M Verma
Systems Biology of Metabolic and Signaling Networks: Energy, Mass and …, 2014
12014
Inferring the metabolic and transcriptional networks specific to Dupuytren’s disease tumours with omics
S Rehman
Metabolomics & Systems Biology 2 (7), 122, 2013
2013
555 mediated BCR. ABL protein regulation in chronic myeloid leukaemia vis-a-vis therapeutic strategies
M Verma, EG Karimiani, RJ Byers, S Rehman, HV Westerhoff, PJ Day
Integrative Biology 5 (3), 543-554, 2013
2013
A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells
S Rehman, A Daskalaki, C Wierling, J Adjaye
2012
A Systems Approach to Understanding Dupuytren's Disease
S Rehman
PQDT-UK & Ireland, 2011
2011
Practical Systems Biology
A Hetherington, C Grierson
Taylor & Francis, 2008
2008
The system can't perform the operation now. Try again later.
Articles 1–20